Diptheria Pertussis Tetanus (Dpt)Vaccine Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units

Reference Brands: Daptacel®, Infanrix®(US); Boostrix® ,Tripedia® (EU)

Category: Hepatitis

Diptheria Pertussis Tetanus (dpt)vaccine is available in Injection and strengths such as Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Diptheria Pertussis Tetanus (dpt)vaccine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Diptheria Pertussis Tetanus (dpt)vaccine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: The Diphtheria, Pertussis, Tetanus (DPT) vaccine injection is a combined immunization product providing protection against three serious bacterial diseases. It contains standardized doses of diphtheria toxoid (≥30 IU), tetanus toxoid (≥40 IU), and whole-cell or acellular pertussis antigens per 0.5 mL dose. Administered intramuscularly, it is essential in pediatric vaccination schedules to prevent diphtheria, whooping cough, and tetanus. Manufactured under stringent EU-GMP and USFDA standards, the DPT vaccine is widely supplied for hospital tenders, public health programs, and B2B distribution in the EU and US markets, supporting immunization coverage worldwide.